HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

CMC544 (Inotuzumab Ozogamicin)

a CD22-targeted immunoconjugate of calicheamicin for the treatment of B lymphoid malignancies
Also Known As:
Inotuzumab Ozogamicin; CMC-544
Networked: 32 relevant articles (7 outcomes, 11 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kantarjian, Hagop: 6 articles (04/2015 - 06/2013)
2. O'Brien, Susan: 6 articles (04/2015 - 06/2013)
3. Thomas, Deborah: 6 articles (04/2015 - 06/2013)
4. Damle, Nitin K: 5 articles (04/2011 - 03/2004)
5. Jabbour, Elias: 4 articles (10/2015 - 08/2013)
6. Dougher, Maureen M: 4 articles (04/2011 - 03/2004)
7. DiJoseph, John F: 4 articles (04/2011 - 03/2004)
8. Ravandi, Farhad: 3 articles (03/2015 - 06/2013)
9. Rytting, Michael: 3 articles (03/2015 - 08/2013)
10. Vandendries, Erik: 3 articles (02/2013 - 04/2010)

Related Diseases

1. Non-Hodgkin Lymphoma (Lymphosarcoma)
2. B-Cell Lymphoma (Lymphoma, B Cell)
3. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
4. Neoplasms (Cancer)
5. Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)

Related Drugs and Biologics

1. rituximab (Mabthera)
2. Immunoconjugates (Immunoconjugate)
3. CMC544 (Inotuzumab Ozogamicin)
4. hLL2 agent (epratuzumab)
5. Doxorubicin (Adriamycin)
6. bevacizumab
7. Vincristine (Oncovin)
8. Prednisone (Sone)
9. Cyclophosphamide (Cytoxan)
10. Antibodies

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Transplants (Transplant)
3. Drug Therapy (Chemotherapy)
4. Salvage Therapy
5. Stents